UK markets closed

Immunotech Biopharm Ltd (6978.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
3.320-0.110 (-3.21%)
At close: 03:48PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 1.77B
Enterprise value 2.07B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)9.41
Enterprise value/revenue N/A
Enterprise value/EBITDA -6.32

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3-3.38%
S&P500 52-week change 322.38%
52-week high 35.000
52-week low 33.020
50-day moving average 33.572
200-day moving average 33.977

Share statistics

Avg vol (3-month) 340.53k
Avg vol (10-day) 343.81k
Shares outstanding 5514.58M
Implied shares outstanding 6525.02M
Float 84.25M
% held by insiders 155.52%
% held by institutions 16.56%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-16.74%
Return on equity (ttm)-99.07%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -187.94M
Net income avi to common (ttm)-334.82M
Diluted EPS (ttm)-0.700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)176.97M
Total cash per share (mrq)0.34
Total debt (mrq)457.17M
Total debt/equity (mrq)267.53%
Current ratio (mrq)1.05
Book value per share (mrq)0.34

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A